Skip to content

13F-HR filed by Prosight Management, LP

Prosight Management, LP filed this 13F-HR for the quarter ended 2022-03-31, filed 2022-05-16, with 32 holding rows worth $154,864,000.

Accession
0001420506-22-001078
Filed
2022-05-16
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2022

A holdings report, 32 entries on the cover page, a total value of $154,864,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $154,864,000 with VALUE read as thousands by filing date, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR374,000$23,195,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock566,538$20,718,000thousands by filing date
ALBIREO PHARMA INC01345P106COMMON STOCK480,000$14,318,000thousands by filing date
GALAPAGOS NV36315X901SPON ADR195,000$12,094,000thousands by filing datecall
CHARLES RIV LABS INTL INC159864107COM31,500$8,945,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM589,270$8,686,000thousands by filing date
CUE BIOPHARMA INC22978P106COM1,510,282$7,370,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM1,400,239$6,224,000thousands by filing date
MEIRAGTX HOLDINGS PLCG59665102COMMON STOCK380,700$5,273,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM300,000$4,986,000thousands by filing date
CONVEY HEALTH SOLUTIONS HLDG21258C108CMN748,134$4,893,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock22,704$3,707,000thousands by filing date
AGILON HEALTH INC00857U107COM140,000$3,549,000thousands by filing date
SHATTUCK LABS INC82024L103COMMON STOCK798,718$3,403,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM203,268$3,224,000thousands by filing date
QUIDEL CORP74838J101COM25,675$2,887,000thousands by filing date
ENCOMPASS HEALTH CORP COM29261A100Stock39,900$2,837,000thousands by filing date
OSCAR HEALTH INC687793109CL A237,500$2,368,000thousands by filing date
ACCOLADE INC00437E102COM124,393$2,184,000thousands by filing date
SELECT MED HLDGS CORP81619Q105COM90,788$2,178,000thousands by filing date
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock34,000$2,134,000thousands by filing date
INMODE LTD SHSM5425M103Stock50,000$1,846,000thousands by filing date
MIRUM PHARMACEUTICALS INC604749101COM73,930$1,628,000thousands by filing date
GLOBUS MED INC CL A379577208Stock18,000$1,328,000thousands by filing date
ARS PHARMACEUTICALS INC82835W108COM325,365$1,142,000thousands by filing date
NEOGENOMICS INC64049M209COM NEW63,524$772,000thousands by filing date
ORGANON & CO68622V956Equity Put20,000$699,000thousands by filing dateput
COGNITION THERAPEUTICS INC19243B102COM240,080$660,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO599,288$542,000thousands by filing date
SIO GENE THERAPIES INC829399104COM670,300$449,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM20,000$333,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM93,923$292,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-22-001078this filing2022-05-16acceptance time not in the bulk data set